Stock TSBX TURNSTONE BIOLOGICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News Turnstone Biologics Corp.

Equities

TSBX

US90042W1009

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
3.05 USD +6.27% Intraday chart for Turnstone Biologics Corp. +12.13% +19.84%
Apr. 16 Turnstone Biologics Corp. Announces Board Changes CI
Mar. 21 Turnstone Biologics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
GL
Turnstone Biologics Appoints William Waddill to its Board of Directors
GL
Turnstone Biologics Corp. Announces Board Changes
CI
Turnstone Biologics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
GL
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
AQ
Turnstone Biologics to Participate in Upcoming Investor Conferences
AQ
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
GL
Turnstone Biologics Corp. Announces Demise of P. Joseph Campisi, Jr., Esq, Chief Legal Officer
CI
Certain Common Stock of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.
CI
Certain Stock Options of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.
CI
Turnstone Biologics Falls 11% in Premarket Activity Tuesday After Surging 42% in Previous Regular Trading Session
MT
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
GL
Turnstone Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
GL
Top Premarket Gainers
MT
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
GL
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
AQ
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte Therapy in Solid Tumors At the 2023 Society for Immunotherapy of Cancer Annual Meeting
CI
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TSBX Stock
  4. News Turnstone Biologics Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW